A2 DISCOVER Trademark

Trademark Overview


On Friday, February 15, 2019, a trademark application was filed for A2 DISCOVER with the United States Patent and Trademark Office. The USPTO has given the A2 DISCOVER trademark a serial number of 88303958. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 13, 2021. This trademark is owned by A2 Biotherapeutics, Inc.. The A2 DISCOVER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

T-cell pharmaceutical products for the treatment of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, namely, proteins and protein complexes for in-vitro diagnostic use for the treatment of cancer

Provision of, and identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer
a2 discover

General Information


Serial Number88303958
Word MarkA2 DISCOVER
Filing DateFriday, February 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements


Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a capital letter "A", adjacent to a line parallel to the right leg of the "A", with the number "2 appearing between both legs of the "A", and with the word "DISCOVER" underneath, all in the color blue.
Goods and ServicesT-cell pharmaceutical products for the treatment of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, namely, proteins and protein complexes for in-vitro diagnostic use for the treatment of cancer
Goods and ServicesProvision of, and identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 9, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameA2 Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAgoura Hills, CA 91301

Party NameA2 Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAgoura Hills, CA 91301

Trademark Events


Event DateEvent Description
Monday, September 13, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 13, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 2, 2021EXTENSION 2 GRANTED
Tuesday, February 2, 2021EXTENSION 2 FILED
Tuesday, February 2, 2021TEAS EXTENSION RECEIVED
Wednesday, July 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020EXTENSION 1 GRANTED
Monday, July 20, 2020EXTENSION 1 FILED
Monday, July 20, 2020TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 14, 2019ASSIGNED TO LIE
Tuesday, November 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 2, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2019NON-FINAL ACTION E-MAILED
Thursday, May 2, 2019NON-FINAL ACTION WRITTEN
Thursday, April 25, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, March 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 19, 2019NEW APPLICATION ENTERED IN TRAM